SP-13786 is primarily researched for its potential therapeutic applications, particularly in the field of oncology. It has shown promise as an inhibitor of specific signaling pathways that are crucial for cancer cell survival and proliferation. Studies suggest that it may be effective in targeting certain types of cancers by disrupting the activity of key proteins involved in tumor growth and metastasis. Additionally, SP-13786 is being explored for its role in enhancing the efficacy of existing cancer treatments, such as chemotherapy, by sensitizing cancer cells to these therapies. Its application is still in the experimental stage, with ongoing research focused on understanding its mechanisms and optimizing its use in clinical settings.